Stomach cancer

Stomach cancer is a common oncological disease in which epithelial cells of the mucous membrane the lining of the stomach grows a malignant tumor. It can form in any part of the body, and in In the process of its development, it infects neighboring tissues and organs, such as the esophagus, liver, lungs, etc. The highest rates of morbidity, as well as mortality from stomach cancer, were recorded in Japan, Brazil, Finland and Russia. Scientists attribute this phenomenon to the dietary habits, lifestyle of the population and unfavorable conditions in these regions. (for example, an unfavorable ecological situation).

The vast majority of cases are people over 50. However, in recent years there has been an alarming trend: more and more malignant gastric tumors are diagnosed in younger patients. According to some sources, stomach cancer is more common in men (32%) than women (21%).

In our oncology department, highly qualified specialists carry out accurate diagnosis and effective treatment of stomach cancer. Call us or sign up online.

Causes of stomach cancer

As with other malignant tumors, there is no one specific cause or factor that leads to the development of cancer. But there are still general patterns in this oncological disease.

  • Incorrect diet. According to research, excessive content in the diet of starchy foods and animal fats, salt, nitrates, as well as a lack of fresh vegetables, fruits and animal proteins can provoke the development of stomach cancer. Factors that predispose to this disease also include alcohol abuse, smoking, poor chewing and an irregular diet.
  • Chronic diseases of the stomach. Tumor development can be a consequence of chronic peptic ulcer, chronic gastritis, gastroduodenal reflux. For example, as a result of prolonged inflammatory processes in the gastric mucosa (with chronic gastritis) or gastroduodenal reflux, characterized by the entry of bile and duodenal contents into the stomach, the gastric epithelium is converted into intestinal. This process, called epithelial metaplasia, is the impetus for the development of malignant tumors.
  • Malignant polyps are another common cause of stomach cancer.
  • Heredity. The risk of getting stomach cancer is higher in people whose close relatives suffered from it. Perhaps, due to genetic characteristics, this oncological disease is more common in men than women. There is also evidence that indicates a relationship between the risk of developing stomach cancer with nationality, blood type (people with blood type A (II) are more common among patients with carcinoma) and other factors. Some hereditary diseases (pernicious anemia, hypogammaglobulinemia, non-polyposis colon cancer) and age over 70 also increase the risk.
  • Helicobacter pylori (H. Pylori). This bacterium causes peptic ulcer disease, chronic gastritis and increases the likelihood of developing a malignant tumor in the stomach.

Other risk factors:

  • ulcers, adenomatous polyps, metaplasia of the gastric mucosa, familial adenomatous polyposis, Menetrier's disease, other cancers (esophagus, bladder, testicles, prostate, mammary glands and ovaries);
  • stomach surgery;
  • low social status and income level;
  • harmful production (in the fields of metallurgy, rubber production, in the coal industry);
  • Immunodeficiency

Classification of stomach cancer

Without the correct classification of stomach cancer, it is impossible to choose the right treatment tactics, type of operation, and predict life for the patient. The old classification distinguished the following types of stomach cancer: intestinal (when the inner mucous layer of the stomach acquires the features of the intestinal mucosa), diffuse (cancer cells spread along the wall of the stomach) and mixed. Today, stomach cancer is classified according to many parameters:

  • Stomach cancer site. Tumors are divided into groups according to localization in certain parts of the stomach: fundus, body, cardiac, pyloric and antrum.
  • Histological structure of the tumor. The tactics of treating gastric cancer also largely depends on the histological structure of the tumor, according to which adenocarcinoma (diagnosed in 95% of clinical cases), squamous, small cell and undifferentiated types of cancer are distinguished. The most common stomach cancer is adenocarcinoma, which develops from the glandular cells of the mucous membrane. Squamous cell carcinoma of the stomach - from epithelial cells. A tumor of the stomach can also form from immune cells (this cancer is called lymphoma), cells that produce hormones (carcinoid), etc.
  • Tumor stage. This factor is also one of the key factors in choosing the tactics of treating gastric cancer and predicting the future fate of the patient. Gastric cancer can be early (initial), when a malignant tumor covers only the mucous membrane, and widespread, when it grows into other layers. But a more accurate classification of gastric cancer by stage takes into account not only the depth of tumor germination, but the number of affected nearby lymph nodes and the presence of distant metastases - this is the international TNM system, so named according to three main criteria:
    • T is the depth of tumor invasion into the wall of the stomach, neighboring organs and adjacent tissues: T0 - the tumor is not detected in the stomach, T1 - the tumor affects only the gastric mucosa, T2 - it has affected the muscle layer, T3 - the tumor has reached the outer layer of the stomach, T4 - the lesion has affected the outer shell and adjacent tissues.
    • N - number of affected regional lymph nodes: N0 - no metastasis in regional lymph nodes, N1 - metastases in 1-2 lymph nodes, N2 - in 3-6, N3 - metastases in more than six lymph nodes.
    • li>
    • M - presence of distant metastases: M0 - no distant metastases, M1 - distant metastases.

Four stages of stomach cancer (adenocarcinoma):

  • I - the tumor does not affect the muscular layer of the stomach, it is localized exclusively in its submucosal and mucous membrane. There are no metastases in the lymph nodes and other organs.
  • II - the germination of the tumor already affects the muscular membrane of the stomach, but is still inside it, not spreading beyond its serous cover. There may be single metastases in the lymph nodes near the wall of the stomach.
  • III - the tumor is enlarged (may spread to several parts of the stomach), grows into adjacent tissues and organs. Cases with multiple metastases of gastric cancer in the regional lymph nodes fall into the same category.
  • IV - all cases in which distant metastases are diagnosed. The size of the tumor does not matter. The prognosis is unfavorable.

Metastases are cancer cells that enter the blood and lymph and spread throughout the body. With lymph, metastases of gastric cancer enter the lymph nodes, first in the abdominal cavity, then in the supraclavicular lymph nodes, as well as in those that surround the rectum. With blood, metastases enter the liver, and in some cases, the lungs. Metastases of stomach cancer can get to the ovaries, to the navel, and, in rare cases, to the bones and brain.

Symptoms and signs of stomach cancer

The following symptoms indicate stomach cancer:

  • weakness, decline in performance;
  • poor or no appetite;
  • Sudden weight loss for no apparent reason;
  • pain and discomfort in the stomach area;
  • anemia;
  • a sharp change in taste;
  • feeling full.

The first symptoms and clinical picture of the tumor in different parts of the stomach may differ. If stomach cancer has affected the cardia (upper part of the organ), symptoms of a malignant tumor will be problems with swallowing large pieces and coarse food (dysphagia), increased salivation. With the worsening of the situation, pain, vomiting, heaviness in the chest and between the shoulder blades can be added to these symptoms.

If the tumor is localized in the lower part of the stomach (in the antrum), the patient will be disturbed by problems with stagnation of food in the stomach and symptoms such as heaviness in the abdomen, belching, vomiting, bad breath.

But often, in the early stages, stomach cancer may be asymptomatic or the symptoms may overlap. with other diseases, for example, with chronic diseases of the stomach.

Clinical manifestations depend on the stage and spread of the disease. With its deterioration, the symptoms of stomach cancer become more pronounced: persistent pain in the stomach area, which can radiate to the back, frequent heartburn, vomiting immediately after eating, an increase in the abdomen, a bulging formation noticeable to the touch under the pit of the stomach is a sign that the tumor has grown into the anterior wall of the abdominal cavity. Further, the symptoms are aggravated, black stools appear or vomiting is black or with blood due to gastric bleeding. From the loss of blood, the patient appears pallor, dizziness.

If you have the above symptoms, please contact the oncology department of our clinic for an examination. You can contact us on the website or by phone.

Complications of stomach cancer

The most common complications of gastric cancer are bleeding and stenosis (complicated passage of food due to narrowing of the gastric fornix by the tumor).

  • Bleeding. A malignant tumor begins to bleed under the influence of acidic gastric juice or as a result of the collapse of a large tumor. This process is accompanied by increased weakness, the appearance of dizziness, a drop in hemoglobin levels. If stomach cancer has grown into large vessels, destroying their walls, bleeding can be very pronounced. Weakness and dizziness increase, “black dots” may appear before the eyes, fainting occurs. Another common symptom of stomach bleeding is coffee grounds vomiting. (this is what blood looks like after contact with gastric juice). Another characteristic sign of severe bleeding is a change in the consistency of feces to tarry or liquid and a change in color to black.
  • Stenosis. This is the name given to the closure of the lumen of the stomach by a tumor, which makes it difficult for food to pass. In the vast majority of cases, stenosis accompanies malignant tumors located in the pyloric (outlet) part of the stomach. As a result, food stagnates, causing an unpleasant feeling of heaviness, belching "rotten", vomiting of food eaten the day before. Also, with stenosis, the feeling of weakness quickly increases, the patient loses weight rapidly, iron and protein levels are greatly reduced, dehydration is possible and convulsive conditions (due to electrolyte imbalance).

Stomach cancer diagnosis

The main method for diagnosing stomach cancer is fibrogastroscopy with tumor biopsy and histological (morphological) examination of the biopsy material. This is the only reliable and trustworthy method for the primary detection of malignant tumors in the stomach.

It is difficult to visualize and differentiate gastric cancer in the early stages, which is why it is critical to use high-quality video endoscopic equipment with the ability to enlarge the image and conduct a narrow-spectrum examination. Such equipment makes it possible to detect stomach cancer at the earliest stages, including when the lesion area is only a few millimeters.

The objectivity and accuracy of diagnosis is ensured by multifocal biopsy and the use of special vital dyes. Contrast-enhanced helical computed tomography (MSCT) is required to determine the stage of development and draw up a treatment plan for gastric cancer.

For the diagnosis of stomach cancer, patients may also be prescribed:

  • radiography;
  • computed tomography;
  • positron emission tomography;
  • Diagnostic laparoscopy;
  • blood test and other laboratory tests.

Early diagnosis of stomach cancer. Screening

In most cases, people learn about the diagnosis already in the later stages, when the malignant tumor has grown into neighboring tissues and metastasized. The treatment of this type of cancer is complex. To "catch" stomach cancer in the early stages, screening is carried out - this is a regular examination of asymptomatic patients using endoscopic examination (gastroscopy). It consists of inserting a tube with a camera into the stomach.

In our oncology department, a comprehensive examination of patients is carried out for the early detection of oncological diseases. Call us or leave a request online and we will contact you as soon as possible.

Methods of treatment of stomach cancer

Today, the main radical treatment for gastric cancer is still surgical intervention: gastrectomy and resection of the stomach (subtotal distal and subtotal proximal). The main condition for surgery is the possibility of extracting the affected stomach or part of it together with the regional lymph nodes and the surrounding tissue.

Surgical treatment of stomach cancer is also combined with chemotherapy and radiation therapy. The type and sequence of treatment is determined individually for each patient, taking into account the type, structure, localization and prevalence of the tumor process, as well as the history and age of the patient.

Surgical removal of stomach cancer.

The main types of surgical removal of malignant tumors in the stomach:

  • Subtotal gastrectomy, in which most of the stomach is removed, except for the cardia. At stages I and II of gastric cancer, as well as when the tumor is localized in the antrum of the stomach, lymph node dissection is also performed during the operation (the affected lymph nodes are removed).
  • Total gastrectomy is the complete removal of the stomach. This operation is performed as a last resort. If at least ¼ of the organ can be saved, complete removal of the stomach is not performed.

Both of these types of surgery involve restoring the integrity of the GI tract through anastomoses (connections) between the small intestine (jejunum or duodenum) and the esophagus or the remaining upper portion of the stomach.

The development of modern medicine in the early (I and II) stages allows surgical treatment of gastric cancer using laparoscopy (endovideosurgery) - less invasive compared to the above options for surgery. Removal of affected areas is carried out through punctures, only a small incision is required to extract the removed material.

Thanks to advances in science and technology, so-called "early cancer" is also treated with endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD). But these methods are effective and possible only if a tumor is detected at the earliest stages, when cancer cells have not had time to leave the polyp or the gastric mucosa.

Radiotherapy

Radiotherapy for stomach cancer is used before surgery (neoadjuvant radiation therapy) to reduce the size of the malignant tumor, make it operable and facilitate surgery, and after surgery (adjuvant radiation therapy) to remove cancer cells that are left after removal tumors. Radiation therapy has side effects: nausea, diarrhea, and there may be digestive disorders.

Chemotherapy

Chemotherapy is also used in the treatment of gastric cancer before or after surgery and, accordingly, is adjuvant and neoadjuvant. Chemotherapy is often combined with radiation therapy (chemoradiation therapy). If gastric cancer is already at the last stage 4 and surgery is not possible, chemotherapy is used as an independent method, but, in this case, palliative treatment. That is, with the help of chemotherapy in such situations, it is possible to reduce the size of a malignant tumor, alleviate the symptoms of the disease and prolong the life of the patient.

Targeted drugs are sometimes used to treat stomach cancer.

Prognosis of life for patients with stomach cancer

Prognosis depends on the stage of the tumor and the gastric cancer at which it was discovered. To assess the effectiveness of treatment, an indicator is used - five-year survival - the percentage of people who remained alive within five years after diagnosis. In the early stages, forecasts are more optimistic. For example, endoscopic treatment of gastric cancer, when cancer cells are detected in a polyp of the stomach or a tumor that has not had time to affect tissues and organs outside the gastric mucosa, makes a complete recovery of the patient possible. The survival rate of patients with stage I disease with timely surgical treatment of gastric cancer is optimistic 80-90%.

At stages II-III, the prognosis is very dependent on the morphological structure of the neoplasm and the number of metastases in the regional lymph nodes (the more there are, the more disappointing the prospects).

At stage IV, the prognosis is unfavorable, the chance for recovery is possible only with the complete removal of the malignant tumor using an extended operation.

Important: in the absence of an appropriate operation, the prognosis for all patients, regardless of the stage of gastric cancer, is disappointing and differs only in life expectancy from the onset of symptoms of the disease to the development of complications. On average, according to statistics from specialized literature, this period is up to 1 year.

In the oncology department of the K + 31 clinic in Moscow, we carry out diagnostics of the whole organism and any pathological process, determine tumor markers, treat cancer of the breast, gastrointestinal tract, liver, diseases such as sarcoma, melanoma and other pathologies . For diagnostics, radiation and chemotherapy, we have modern equipment, our doctors use only effective methods and proven drugs that are successfully undergoing clinical trials.

Call us by phone or contact us on the website, and we will call you back.

Service record



Specialists

All specialists
Merkulov
Igor Alexandrovich

Deputy chief physician for oncology, oncologist

Doctor of Sciences, PhD

Lyadov
Konstantin Viktorovich

Academician, professor, Doctor of Sciences, PhD

Petrov
Dmitry Yurevich

Deputy chief physician for oncology, surgeon

PhD, Docent

Ershova
Ksenia Igorevna

Head of department, oncologist

PhD

Abashin
Sergey Yuryevich

Head of oncology projects, oncologist

Doctor of Sciences, PhD, professor

Rasner
Pavel Ilyich

Consultant in urology, urologist

Doctor of Sciences, PhD, professor

Malygin
Sergey Evgenyevich

Oncologist-mammologist, surgeon

Pshikhachev
Ahmed Mukhamedovich

Urologist, Oncologist

Doctor of Sciences, PhD

Shevchuk
Alexei Sergeyevich

Oncogynecology consultant, obstetrician-gynecologist

PhD

Chichkanova
Tatyana Vladimirovna

Oncologist-mammologist, radiologist

Katz
Ksenia Vladimirovna

Dermatovenerologist, oncologist

Udin
Oleg Ivanovich

Deputy chief physician for surgery, surgeon

PhD

Kogonia
Lali Mikhailovna

Chemotherapist

Doctor of Sciences, PhD

Ushenina
Maria Valerievna

Oncologist-chemotherapist

PhD

Volkova
Daria Mikhailovna

Head of the radiation therapy department

Gomov
Mikhail Alexandrovich

Consultant in oncogynecology, obstetrician-gynecologist

Grishin
Igor Igorevich

Obstetrician-gynecologist

Doctor of Sciences, PhD, professor

Achba
Maya Otarovna

Radiologist, ultrasound diagnostician, oncologist-mammologist

Dubinina
Yulia Nikolaevna

Head of the oncology department of antitumor drug therapy, oncologist, hematologist